Back
Plus Therapeutics Stock Predictions
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
35
PSTV
Plus Therapeutics
Last Price:
1.19
Seasonality Move:
7.07%
7 Day Trial
ALL ACCESS PASS
$
7
Start Investing Smarter Unlock Louis Navellier's Stock Grader for free
Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.Plus Therapeutics Stock Forecast
-
Is Plus Therapeutics Stock Undervalued?
The current Plus Therapeutics [PSTV] share price is $1.19. The Score for PSTV is 35, which is 30% below its historic median score of 50, and infers higher risk than normal. - PSTV is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Plus Therapeutics Stock Go Up Next Year?
Data Unavailable
Plus Therapeutics Stock Rating
Data Unavailable
Plus Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
plustherapeutics.com
52-Week Data
52-Week High:
2.67
52-Week Low:
1.15
Prediction Charts
Market Cap:
7.02M
Price in USD:
1.19
Volume:
15.22K
Beta:
1.30
Technical Analysis
SMA50:
1.39
SMA100:
1.49
SMA200:
1.71
52-Wk Change:
-37.37%
Stock Predictions
-
Is Plus Therapeutics stock public?
Yes, Plus Therapeutics is a publicly traded company. -
What is the Plus Therapeutics stock quote today?
The Plus Therapeutics stock price is 1.19 USD today. -
How to buy Plus Therapeutics stock online?
You can buy Plus Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-1 | 1.33 | 1.35 | 1.37 | 1.32 |
| Nov-4 | 1.38 | 1.36 | 1.38 | 1.33 |
| Nov-5 | 1.45 | 1.36 | 1.45 | 1.33 |
| Nov-6 | 1.26 | 1.41 | 1.49 | 1.17 |
| Nov-7 | 1.30 | 1.36 | 1.38 | 1.25 |
| Nov-8 | 1.33 | 1.23 | 1.33 | 1.22 |
| Nov-11 | 1.25 | 1.17 | 1.27 | 1.17 |
| Nov-12 | 1.25 | 1.29 | 1.34 | 1.18 |
| Nov-13 | 1.27 | 1.31 | 1.42 | 1.25 |
| Nov-14 | 1.26 | 1.26 | 1.32 | 1.25 |
| Nov-15 | 1.28 | 1.17 | 1.29 | 1.16 |
| Nov-18 | 1.21 | 1.19 | 1.21 | 1.17 |
| Nov-19 | 1.22 | 1.24 | 1.24 | 1.18 |
| Nov-20 | 1.22 | 1.19 | 1.24 | 1.19 |
Plus Therapeutics Earnings
Data Unavailable
Plus Therapeutics Forecast Revenue Growth
Data Unavailable
- Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.87 per share, and a decrease next year of $0.03 per share.
* Plus Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.